• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number UNK AMPLATZER SEPTAL OCCLUDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombosis/Thrombus (4440); Heart Block (4444)
Event Date 09/01/2013
Event Type  Injury  
Event Description
The article "clinical and procedural characteristics of successful transcatheter device closure of ostium secundum atrial septal defect in symptomatic children weighing <15 kg: a retrospective study spanning one decade from south>india" was reviewed.The article presented a retrospective single center study, to evaluate the feasibility of transcatheter atrial septal defect device closure in patients less than 15 kg, as well as to assess complication rates and the reasons for unsuccessful device closure.Devices mentioned include amplatzer atrial septal defect (asd) occluder.The article concluded that *conclusion*.[the primary author and corresponding author was shohiab u.R.Mirza at , christian medical college vellore, india with corresponding email shohiab.Riyaz@gmail.Com.The time frame of the study was september 2013 to february 2022.A total of 81 patients were included in this study, of which 20 received an abbott device.Out of 81 patients, the median age was 3.The majority gender was female.Median weight was 12 kg.Comorbidities include failure to thrive, recurrent lower respiratory tract infection, pulmonary stenosis, persistent left superior vena cava, mitral valve prolapse, ventricular septal defect, dyspnea on exertion, right axis deviation, incomplete right bundle branch block, right ventricular hypertrophy, complete right bundle branch block, first degree atrioventricular block, junctional rhythm, tricuspid regurgitation, pulmonary artery hypertension.Peri and post procedural complications include right common femoral artery thrombosis, complete heart block, intervention, residual shunt.
 
Manufacturer Narrative
The additional patient effect of malfunction reported in the article is captured under a separate medwatch report.B3 - as this event is from a literature review, the event date is estimated.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
Summarized patient outcomes/complications of clinical and procedural characteristics of successful transcatheter device closure of ostium secundum atrial septal defect in symptomatic children weighing <15 kg: a retrospective study spanning one decade from south>india were reported in a research article in a subject population with multiple co-morbidities including failure to thrive, recurrent lower respiratory tract infection, pulmonary stenosis, persistent left superior vena cava, mitral valve prolapse, ventricular septal defect, dyspnea on exertion, right axis deviation, incomplete right bundle branch block, right ventricular hypertrophy, complete right bundle branch block, first degree atrioventricular block, junctional rhythm, tricuspid regurgitation, pulmonary artery hypertension.Some of the complications reported were right common femoral artery thrombosis, complete heart block, intervention, residual shunt these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature attachment: article title clinical and procedural characteristics of successful transcatheter device closure of ostium secundum atrial septal defect in symptomatic children weighing <15 kg: a retrospective study spanning one decade from south>india.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key19201579
MDR Text Key341267061
Report Number2135147-2024-01873
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER SEPTAL OCCLUDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/04/2024
Initial Date FDA Received04/29/2024
Supplement Dates Manufacturer Received05/08/2024
Supplement Dates FDA Received05/24/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-